amonafide has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, DS; Craig, JB; Liu, PY; Malviya, VK; O'Sullivan, J; O'Toole, R; Rosenoff, S; Surwit, E; Ward, JH; Yu, A | 1 |
| Asbury, R; Blessing, JA; McGuire, WP; Reid, GC | 1 |
2 trial(s) available for amonafide and Endometrial Neoplasms
| Article | Year |
|---|---|
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Middle Aged; Naphthalimides; Neoplasm Recurrence, Local; Organophosphonates; Survival Analysis; Treatment Outcome | 1994 |
A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group Study.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates | 1998 |